Last reviewed · How we verify
NCT02944188
Laparoscopic Versus Open Right Hemicolectomy Within ERAS in Right-sided Colon Cancer
NA trial testing Laparoscopic right hemicolectomy plus ERAS in Colon Cancer in 602 participants. Completed in 30 December 2020.
30 December 2017
Quick facts
| Lead sponsor | Xu jianmin |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 602 |
| Start date | 1 December 2014 |
| Primary completion | 30 December 2017 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Laparoscopic right hemicolectomy plus ERAS
- Open right hemicolectomy plus ERAS
Conditions studied
- Colon Cancer — all drugs for Colon Cancer →
Sponsor
Xu jianmin — full company profile →
Who can join
Adults 18 to 75, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the investigators have compared the clinical outcomes of the laparoscopic and open right hemicolectomy within enhanced recovery after surgery (ERAS) programs in the treatment of right-sided colon cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02944188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colon Cancer
Currently open trials in the same condition.
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
- NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting
Other Xu jianmin trials
Trials by the same sponsor.
- NCT06814093 — Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation · active not recruiting
- NCT04118933 — A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer · Phase 2 · unknown
- NCT03895723 — Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases · NA · unknown
- NCT02642978 — Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02944188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xu jianmin
- Last refreshed: 22 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02944188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing